A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer

  1. Rosell, R.
  2. Abad-Esteve, A.
  3. Morera, J.
  4. Monras, P.
  5. Moreno, I.
  6. Ruiz, J.
  7. Fernandez, C.
  8. Ribas-Mundo, M.
Revue:
American Journal of Clinical Oncology: Cancer Clinical Trials

ISSN: 0277-3732

Année de publication: 1987

Volumen: 10

Número: 3

Pages: 245-248

Type: Article

DOI: 10.1097/00000421-198706000-00017 GOOGLE SCHOLAR

Objectifs de Développement Durable

La source de données: Scopus